JOYY rises in premarket after quarterly results
JOYY shares rose 3.6% in premarket trading after the company reported second-quarter earnings of $1.24 per share versus $1.28 expected and sales of $590.754 million versus $574.118 million expected.
Shares of JOYY Inc (NASDAQ: JOYY ) rose sharply in pre-market trading after the company reported financial results for the second quarter.
JOYY reported quarterly earnings of $1.24 per share which missed the analyst consensus estimate of $1.28 per share.
The company reported quarterly sales of $590.754 million which beat the analyst consensus estimate of $574.118 million.
JOYY said it sees third-quarter sales of $602.000 million-$622.000 million, versus market estimates of $591.756 million.
JOYY shares jumped 3.6% to $77.70 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers Reading International Inc (NASDAQ: RDIB ) gained 98.4% to $18.85 in pre-market trading after jumping around 9% on Tuesday.
YY Group Holding Ltd (NASDAQ: YYGH ) rose 74% to $2.00 in pre-market trading after the company announced the cancellation of a $5.94 million second financing tranche and all outstanding warrants.
CID HoldCo Inc (NASDAQ: DAIC ) rose 44.9% to $5.62 in pre-market trading after surging 124% on Tuesday.
Lucas GC Ltd (NASDAQ: LGCL ) rose 32.1% to $0.058 in pre-market trading after dipping over 6% on Tuesday.
Founder Group Ltd (NASDAQ: FGL ) gained 29.2% to $0.27 in pre-market trading.
On Tuesday, Founder Group announced that it has completed the acquisition of a 19.90% equity interest in Nichcom Go Sdn.
Bhd.
Trugolf Holdings Inc (NASDAQ: TRUG ) gained 27.8% to $0.75 in pre-market trading after declining 10% on Tuesday.
TruGolf recently announced it will acquire tokenization technology company Polymath Research For ~19.9% Of TRUG Class A Shares Outstanding.
Expion360 Inc (NASDAQ: XPON ) rose 25% to $6.59 in pre-market trading after dropping 15% on Tuesday.
Expion360 recently announced a $3.425 million acquisition of Eastern Louisiana Oil ans Gas Exploration Prospect.
Biohaven Ltd (NYSE: BHVN ) rose 9.6% to $15.76 in pre-market trading.
Biohaven and SK Biopharmaceuticals entered into a strategic global licensing agreement for novel Kv7 ion channel platform and opakalim, lead candidate for epilepsy.
Anbio Biotechnolog y (NASDAQ: NNNN ) shares gained 7.4% to $8.41 in pre-market trading.
Losers Greenland Mines Ltd (NASDAQ: GRML ) tumbled 29% to $6.90 in pre-market trading after announcing a proposed public offering.
Netcapital Inc (NASDAQ: NCPL ) fell 24.8% to $0.44 in pre-market trading after jumping over 126% on Tuesday.
Xiao-I Corp (NASDAQ: AIXI ) fell 16.8% to $1.09 in pre-market trading after jumping 186% on Tuesday.
Xiao-I recently announced it will change its ADS ratio from 1—to—60 to 1—to—420 ordinary shares and disclosed it received a non—compliance notice from Nasdaq.
Akanda Cor p (NASDAQ: AKAN ) declined 15% to $4.21 in pre-market trading after jumping 34% on Tuesday.
Advasa Holdings (NASDAQ: ADBT ) fell 14.1% to $5.38 in pre-market trading after dipping around 48% on Tuesday.
Advasa Holdings, on Tuesday, completed a direct listing on Nasdaq under the ticker symbol “ADBT”.
Biodexa Pharmaceuticals PLC-ADR (NASDAQ: BDRX ) fell 13.6% to $1.02 in pre-market trading.
707 Cayman Holdings Ltd (NASDAQ: JEM ) fell 12.4% to $5.95 in pre-market trading.
707 Cayman Holdings shares jumped 78% on Tuesday after the company announced signing of a term sheet to acquire Crucial Innovation, supported by $10.25 million financing led by GeoNova Holdings.
Spyre Therapeutics In c (NASDAQ: SYRE ) fell 12.3% to $94.16 in pre-market trading after the company announced topline results from the RA sub-study of its Phase 2 SKYWAY basket trial evaluating SPY072 in rheumatic diseases.
The results did not meet the company’s internal bar to prioritize advancement of SPY072 in RA.
Intuit Inc (NASDAQ: INTU ) fell 11.7% to $315.50 in pre-market trading after the company reported upbeat fourth-quarter financial results but issued FY27 guidance below estimates.
Zoom Communications In c (NASDAQ: ZM ) fell 5.8% to $95.10 in pre-market trading as the company reported better-than-expected financial results for the second quarter but issued soft guidance for the third quarter.
Photo via Shutterstock